middle.news
How Hydralyte USA’s Record EBITDA Signals a US Turnaround
11:45pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Hydralyte USA’s Record EBITDA Signals a US Turnaround
11:45pm on Monday 2nd of June, 2025 AEST
Key Points
April 2025 net sales of US$229,000 with 66% gross margin
May 2025 sales exceed US$260,000, continuing upward trend
April EBITDA loss narrows by 131% from March, best since IPO
Completion of non-US asset divestiture reduces operating costs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
The Hydration Pharmaceuticals Company (ASX:HPC)
OPEN ARTICLE